StockData
Johnson & Johnson logo

Johnson & Johnson (JNJ) operating KPIs

JNJNYSEPharmaceutical PreparationsFiscal year ends January 3
Financials through Q2 FY2026, quarter ended Jun 28, 2026Last filing: 10-Q on Oct 21, 2026Score 12/3043% above fair value
$273.20−2.00 (-0.73%)

Close on Oct 30, 2026Market cap $658.38BP/E 31.7Yield 1.88%

Johnson & Johnson consumer Health identifiable assets ($M) [through FY2022] ($M)

Form 10-K Segment Note

Latest, Q4 2022
24,068
Period ended Jan 1, 2023
Change on a year earlier
-4.0%
25,081 in Q4 2021
History
7 quarters
Since Q4 2016
Sources
5
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedConsumer Health identifiable assets ($M) [through FY2022] ($M)Year on yearSource
Q4 2022Jan 1, 202324,068-4.0%Form 10-K (filed 2023-02-16) ↗
Q4 2021Jan 2, 202225,081-8.3%Form 10-K (filed 2023-02-16) ↗
Q4 2020Jan 3, 202127,355+2.8%Form 10-K (filed 2022-02-17) ↗
Q4 2019Dec 29, 201926,618+2.9%Form 10-K (filed 2021-02-22) ↗
Q4 2018Dec 30, 201825,877+3.4%Form 10-K (filed 2019-02-20) ↗
Q4 2017Dec 31, 201725,030+4.4%Form 10-K (filed 2019-02-20) ↗
Q4 2016Jan 1, 201723,971–Form 10-K (filed 2018-02-21) ↗

Cite this data

StockData. (2026). Johnson & Johnson Consumer Health identifiable assets ($M) [through FY2022] ($M), quarterly Q4 2016–Q4 2022 [Data set]. Compiled from Johnson & Johnson SEC filings and investor materials. https://stockdatahq.com/stocks/jnj/kpis/seg_assets_ch_legacy

See every metric in the Johnson & Johnson KPI table. Data updated Oct 25, 2026.